Bharat Parenterals opened at ₹1,899.90, in line with its previous close of ₹1,899.70. During today's session, the stock has traded between ₹1,857.30 and ₹1,911.90, with an average traded price of ₹1,889.05. It is currently showing a downward intraday trend.
An investment of ₹10,000 made 1 year ago in Bharat Parenterals is now worth
₹ 14,340.00
giving a profit of
₹ 4,340.00 (43.40%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
-25.50 (-1.34%)
Day High
₹1,911.90
Day Low
₹1,857.30
Day Open
₹1,899.90
Prev Close
₹1,899.70
Volume
3,671
Value Traded
₹0.69 Cr
1W Return
8.53%
1M Return
24.52%
3M Return
43.40%
6M Return
43.40%
1Y Return
43.40%
Market Cap (₹ Cr.)
1,292
PE Ratio
-43.50
PB Ratio
4.05
Dividend Yield
0.05%
ROE
-8.76%
ROCE
-1.95%
Book Value (₹)
467.55
Face Value (₹)
10.00
EPS (TTM)
-5.17
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
8.53%
6 Week
-
1 Month
24.52%
3 Month
43.40%
9 Month
43.40%
Bharat Parenterals issues corrigendum on preferential issue disclosures
Bharat Parenterals issued a corrigendum to its EGM notice dated October 23, 2026. Crisil Ratings Limited appointed as monitoring agency for preferential issue. Issue size exceeds ₹100 crore, triggering SEBI Regulation 162A compliance. BSE directed the additional disclosure following application for in-principle approval.
TodayBharat Parenterals schedules EGM on Oct 23 to approve ₹139 crore preferential issue
EGM scheduled for October 23, 2026, via VC/OAVM. Proposal to raise ₹139 crore via preferential issue of 9,12,759 shares. Issue price fixed at ₹1,522.85 per share for 15 non-promoter investors. Proceeds primarily allocated to investment in subsidiaries (₹135 crore). Separate resolution sought to enhance Section 186 limits by ₹140 crore.
12 days agoBharat Parenterals shareholders approve FY26 financials, dividend at AGM
Bharat Parenterals Limited concluded its 33rd AGM on September 19, 2026. Shareholders approved FY26 audited financial statements and final dividend. Mr. Hemang Shah was reappointed as Executive Director after retiring by rotation. All resolutions passed with requisite majority via remote e-voting and AGM voting. Statutory and secretarial auditor reports were unqualified with no adverse observations.
24 days agoBharat Parenterals files FY26 annual report; AGM on September 19
Bharat Parenterals filed its FY26 annual report with BSE on August 27, 2026. The 33rd AGM is scheduled for September 19, 2026, via video conferencing. Record date for dividend eligibility is September 12, 2026. Remote e-voting facility is provided by NSDL.
1mo agoBharat Parenterals equity shares begin trading on NSE
Bharat Parenterals Limited shares began trading on the NSE on August 17, 2026, under the symbol BPLPHARMA. The listing adds to the company's existing presence on the BSE. The move follows regulatory approval under SEBI LODR Regulations.
1mo agoBharat Parenterals doubles capex to ₹300 crore for biologics facility
Bharat Parenterals Limited increases Phase 1 capex for Varenyam Biolifesciences to ₹300 crore to add biologics CDMO capabilities. The Savli facility will target US and EU markets, with completion expected in Q2 2028.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,770.70 | +0.61% | ₹4,24,850.24 | 34.83 | +5.97% | |
| ₹9,285.00 | -1.50% | ₹2,46,487.58 | 85.12 | +43.41% | |
| ₹4,642.90 | -0.84% | ₹1,76,600.99 | 82.55 | +31.42% | |
| ₹1,132.50 | -0.17% | ₹1,12,967.31 | 24.74 | +14.00% | |
| ₹2,059.40 | -0.47% | ₹1,11,271.90 | 102.63 | +134.89% | |
| ₹1,329.60 | +1.40% | ₹1,07,412.86 | 31.62 | -14.87% | |
| ₹1,240.00 | +0.86% | ₹1,03,500.36 | 32.26 | -1.93% | |
| ₹2,372.00 | -1.17% | ₹97,974.30 | 47.92 | -3.57% | |
| ₹1,684.60 | -1.31% | ₹96,928.16 | 26.40 | +49.04% | |
| ₹1,953.60 | +0.96% | ₹89,336.17 | 16.03 | -0.29% | |
| ₹2,265.30 | -0.78% | ₹63,932.35 | 35.82 | +16.81% | |
| ₹5,250.00 | +0.86% | ₹62,771.63 | 28.34 | -3.75% |
An investment of ₹10,000 made 1 year ago in Bharat Parenterals is now worth
₹ 14,340.00
giving a profit of
₹ 4,340.00 (43.40%)
Note: Past profits do not guarantee future returns.
